<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">PRF</journal-id>
<journal-id journal-id-type="hwp">spprf</journal-id>
<journal-id journal-id-type="nlm-ta">Perfusion</journal-id>
<journal-title>Perfusion</journal-title>
<issn pub-type="ppub">0267-6591</issn>
<issn pub-type="epub">1477-111X</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0267659112462733</article-id>
<article-id pub-id-type="publisher-id">10.1177_0267659112462733</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Papers</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A hemolysis study of an intravascular blood cooling system for localized organ tissue cooling</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Merrill</surname><given-names>TL</given-names></name>
<xref ref-type="aff" rid="aff1-0267659112462733">1</xref>
<xref ref-type="aff" rid="aff2-0267659112462733">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Mingin</surname><given-names>T</given-names></name>
<xref ref-type="aff" rid="aff3-0267659112462733">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Merrill</surname><given-names>DR</given-names></name>
<xref ref-type="aff" rid="aff2-0267659112462733">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Botbyl</surname><given-names>J</given-names></name>
<xref ref-type="aff" rid="aff4-0267659112462733">4</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Akers</surname><given-names>JE</given-names></name>
<xref ref-type="aff" rid="aff2-0267659112462733">2</xref>
</contrib>
</contrib-group>
<aff id="aff1-0267659112462733"><label>1</label>Rowan University, Mechanical Engineering Department, Glassboro, NJ, USA</aff>
<aff id="aff2-0267659112462733"><label>2</label>FocalCool, LLC, Mullica Hill, NJ, USA</aff>
<aff id="aff3-0267659112462733"><label>3</label>Rowan University, Department of Biological Sciences, Glassboro, NJ, USA</aff>
<aff id="aff4-0267659112462733"><label>4</label>Provonix Inc., 107 Gilbreth Parkway, Mullica Hill, NJ, USA</aff>
<author-notes>
<corresp id="corresp1-0267659112462733">Thomas L. Merrill, Rowan University, Mechanical Engineering Department, 201 Mullica Hill Rd, Glassboro, NJ 08028, USA Email: <email>merrill@rowan.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>1</month>
<year>2013</year>
</pub-date>
<volume>28</volume>
<issue>1</issue>
<fpage>6</fpage>
<lpage>13</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Therapeutic hypothermia can reduce both ischemic and reperfusion injury arising after strokes and heart attacks. New localized organ cooling systems offer a way to reduce tissue damage more effectively with fewer side effects. To assess initial blood safety of our new organ cooling system, the CoolGuide Cooling System (CCS), we investigated safe operating conditions and configurations from a hemolysis perspective. The CCS consists of a peristaltic pump, a custom-built external heat exchanger, a chiller, biocompatible polyvinyl cellulose (PVC) tubing, and a control console. The CCS cools and circulates autologous blood externally and re-delivers cooled blood to the patient through a conventional catheter inserted directly into the organ at risk. Catheter configurations used included: a 7F guide catheter only, a 7F guide with a 0.038” wire inserted through the center and advanced 2 cm distal to the catheter distal tip, a 6F guide catheter only and a 6F guide with a 0.014” guidewire similarly inserted through the center. Using porcine blood, an in vitro test rig was used to measure the degree of hemolysis generation, defined as the percentage change in free hemoglobin, adjusted for total hemoglobin and hematocrit, between exiting and entering blood. The highest degree of hemolysis generation was 0.11±0.04%, based on the average behavior with a 6F catheter and a 0.014” guidewire configuration at a blood flow rate of approximately 130 mL/min. In terms of average percentage free hemoglobin exiting the system, based on total hemoglobin, the highest value measured was 0.17%±0.03%, using this 6F and 0.014” guidewire configuration. This result is significantly below the most stringent European guideline of 0.8% used for blood storage and transfusion. This study provides initial evidence showing hemolysis generation arising from the CoolGuide Cooling System is likely to be clinically insignificant.</p>
</abstract>
<kwd-group>
<kwd>Hemolysis</kwd>
<kwd>organ cooling</kwd>
<kwd>free hemoglobin</kwd>
<kwd>ischemia</kwd>
<kwd>reperfusion injury</kwd>
<kwd>hypothermia</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0267659112462733" sec-type="intro">
<title>Introduction</title>
<p>Therapeutic hypothermia can reduce both ischemic and reperfusion injury-related damage for a range of organs, including the heart, brain and kidneys.<sup><xref ref-type="bibr" rid="bibr1-0267659112462733">1</xref><xref ref-type="bibr" rid="bibr2-0267659112462733"/><xref ref-type="bibr" rid="bibr3-0267659112462733"/>-<xref ref-type="bibr" rid="bibr4-0267659112462733">4</xref></sup> Most devices achieve therapeutic tissue temperatures by cooling the entire body, a process that is both time-consuming, requiring hours to achieve target temperatures, and may yield harmful side effects such as shivering and delayed wound healing.<sup><xref ref-type="bibr" rid="bibr5-0267659112462733">5</xref><xref ref-type="bibr" rid="bibr6-0267659112462733"/><xref ref-type="bibr" rid="bibr7-0267659112462733"/>-<xref ref-type="bibr" rid="bibr8-0267659112462733">8</xref></sup></p>
<p>To improve the ease of use and patient outcomes, a new intravascular cooling system is being developed to provide localized cooling directly to organs. The CoolGuide Cooling System (CCS) is capable of rapid, localized tissue cooling, decreasing target tissue temperatures by 3 to 5°C in less than five minutes.<sup><xref ref-type="bibr" rid="bibr9-0267659112462733">9</xref></sup></p>
<p>The CCS cools and circulates autologous blood externally and re-delivers cooled blood to the patient through a conventional catheter inserted directly into the organ at risk. As a result, only the organ or parts of the organ are cooled, minimizing systemic cooling. Rapid, localized cooling may ultimately aid in reducing lingering damage from heart attack and stroke as well as problems associated with organ transplantation.</p>
<p>The CCS consists of a fully occlusive peristaltic pump (Watson Marlow, Wilmington, MA), a custom-built external heat exchanger (EHX), a thermoelectric chiller (CustomChill, Philadelphia, PA), biocompatible PVC tubing (Saint Gobain, Valley Forge, PA), and a control console (<xref ref-type="fig" rid="fig1-0267659112462733">Figure 1</xref>). The custom-built EHX is manufactured from a PVC shell together with clear ¼” ID, 3/8” OD, PVC tubing (McMaster-Carr, Robbinsville, NJ). System pumping pressure and flow measurement is achieved by a 0-40 psig in-line pressure sensor (PendoTECH, Princeton, NJ) and an ultrasonic flow probe and meter (Transonic, Ithaca, NY). Type-T thermocouples (Physitemp, Clifton, NJ and Blaze Technical Services, Stow, OH) are used to measure all blood temperatures.</p>
<fig id="fig1-0267659112462733" position="float">
<label>Figure 1.</label>
<caption>
<p>Schematic of the CoolGuide Cooling System (CCS). Autologous blood is pulled from the body using an insertion sheath and pump. Cooled blood is returned to the body using a standard guide catheter. A control console monitors blood pressure, temperature and flow to ensure safe operation</p>
</caption>
<graphic xlink:href="10.1177_0267659112462733-fig1.tif"/>
</fig>
<p>Briefly, in a clinical environment involving an interventional procedure, blood would be pulled through an insertion sheath by the blood pump. Blood would then be transferred via tubing to the EHX for cooling. Finally, the blood would be re-introduced in a cooled state into the body through a conventional guide catheter, achieving localized tissue cooling in the organ of interest. Typical delivered blood flow rates would be 50 to 130 mL/min; delivery temperatures to the organ would be around 25°C.</p>
<p>To achieve regulatory approval for clinical testing, overall blood trauma tests involving hemolysis, complement activation, platelet activation and thrombus formation are necessary.<sup><xref ref-type="bibr" rid="bibr10-0267659112462733">10</xref>,<xref ref-type="bibr" rid="bibr11-0267659112462733">11</xref></sup> The focus of this work is hemolysis testing. Blood temperatures, delivery flow rates and blood pathway geometry all contribute to the resulting shear stress that can cause the mechanical destruction of blood cells.<sup><xref ref-type="bibr" rid="bibr12-0267659112462733">12</xref></sup></p>
<p>While blood damage for other devices, such as needles, catheters, infusion pumps and cardiopulmonary bypass systems, have been studied,<sup><xref ref-type="bibr" rid="bibr13-0267659112462733">13</xref><xref ref-type="bibr" rid="bibr14-0267659112462733"/>-<xref ref-type="bibr" rid="bibr15-0267659112462733">15</xref></sup> no device has been tested that is identical to the CCS. Its hemolysis profile is unknown.</p>
<p>Consider two primary factors behind mechanical destruction of blood cells: shear stress and exposure time.<sup><xref ref-type="bibr" rid="bibr16-0267659112462733">16</xref></sup> <xref ref-type="disp-formula" rid="disp-formula1-0267659112462733">Equation (1)</xref> explains the origin of shear stress in blood flow. It shows a force balance of a differential element of blood as it travels through a circular blood vessel:</p>
<p><disp-formula id="disp-formula1-0267659112462733">
<label>(1)</label>
<mml:math display="block" id="math1-0267659112462733">
<mml:mrow>
<mml:msub>
<mml:mi>τ</mml:mi>
<mml:mi>w</mml:mi>
</mml:msub>
<mml:mspace width="0.25em"/><mml:mn>2</mml:mn><mml:mspace width="0.25em"/><mml:mi>π</mml:mi><mml:mspace width="0.25em"/><mml:mi>R</mml:mi><mml:mspace width="0.25em"/><mml:mi>L</mml:mi><mml:mo>=</mml:mo><mml:mi>Δ</mml:mi><mml:mi>p</mml:mi><mml:mspace width="0.25em"/><mml:mi>π</mml:mi><mml:mspace width="0.25em"/><mml:msup>
<mml:mi>R</mml:mi>
<mml:mn>2</mml:mn>
</mml:msup>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula1-0267659112462733" xlink:href="10.1177_0267659112462733-eq1.tif"/>
</disp-formula></p>
<p>where τ<sub>w</sub> is the shear stress (N/m<sup>2</sup>) at the wall, R is the radius of the vessel (m) and L is the differential length (m) of the fluid element. Δp is the differential pressure. It says that when blood is not accelerating there is a force balance between shear and pressure forces. <xref ref-type="disp-formula" rid="disp-formula2-0267659112462733">Equation (2)</xref> shows the instantaneous shear stress assuming Newtonian flow:</p>
<p><disp-formula id="disp-formula2-0267659112462733">
<label>(2)</label>
<mml:math display="block" id="math2-0267659112462733">
<mml:mrow>
<mml:msub>
<mml:mi>τ</mml:mi>
<mml:mi>w</mml:mi>
</mml:msub>
<mml:mo>=</mml:mo><mml:mfrac>
<mml:mrow>
<mml:mn>4</mml:mn><mml:mi>μ</mml:mi><mml:mi>Q</mml:mi><mml:mo>,</mml:mo>
</mml:mrow>
<mml:mrow>
<mml:mi>π</mml:mi><mml:msup>
<mml:mi>R</mml:mi>
<mml:mn>3</mml:mn>
</mml:msup>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula2-0267659112462733" xlink:href="10.1177_0267659112462733-eq2.tif"/>
</disp-formula></p>
<p>where μ is the dynamic viscosity of blood (kg/(m-s)) and Q is the flow rate (m<sup>3</sup>/s). Newtonian flow is a reasonable assumption for the CCS configurations where shear rates (τ<sub>w</sub>/µ) are greater than 100 sec<sup>-1</sup>.<sup><xref ref-type="bibr" rid="bibr17-0267659112462733">17</xref></sup></p>
<p>Finally, for our testing, the exposure time is equal to the transit time of the blood inside the CCS, calculated by taking the blood flow path length in each subsection of the CCS and dividing by the appropriate blood velocity in each section. In a clinical setting, the entire CCS procedure has an expected duration of approximately 30-45 minutes, including both cooling and rewarming.</p>
<p>The aim of this paper is to identify safe operating conditions and catheter guidewire configurations for localized organ tissue cooling, using the CCS from a hemolysis perspective. Hemolysis testing was performed using a custom-built in vitro setup and porcine blood. Results show that the highest degree of hemolysis generation was 0.11±0.04%, based on the average behavior with a 6F catheter and a 0.014” guidewire configuration at a blood flow rate of approximately 130 mL/min. In terms of average percentage free hemoglobin based on total hemoglobin, the value was 0.17%±0.03%, significantly below the most stringent guideline for transfusion products found in Europe, 0.8%.<sup><xref ref-type="bibr" rid="bibr18-0267659112462733">18</xref></sup> At these conditions, the CCS delivers approximately 79 W of cooling with a minimum blood temperature and system drive pressure of approximately 25°C and 1900 mmHg, respectively. All other configurations using 6F and 7F standard guide catheters at flow ranges between 50 and 130 mL/min had a degree of hemolysis generation at or below 0.05%.</p>
</sec>
<sec id="section2-0267659112462733" sec-type="materials|methods">
<title>Materials &amp; methods</title>
<sec id="section3-0267659112462733">
<title>Experimental setup and materials for hemolysis testing (<xref ref-type="fig" rid="fig2-0267659112462733">Figure 2</xref>)</title>
<p>Porcine blood was obtained from a local slaughterhouse and immediately anticoagulated on site with anticoagulant citrate dextrose (ACD) at a ratio of 9:1 blood to ACD. Porcine blood was selected because of its availability, as well as its similarity to human blood.<sup><xref ref-type="bibr" rid="bibr19-0267659112462733">19</xref></sup> Immediately after collection, blood was filtered using a coarse strainer (pore size approximately 0.9 mm) to remove any large unwanted deposits and was transferred to a 0.5 - L IV bag (Qosina, Edgewood, NY) with a 12F insertion sheath for withdrawing blood directly from the bag. A 15-cm long 6F guide catheter was placed inside the sheath. This blood bag was submersed in a constant temperature bath, maintained at 38±0.5°C throughout the test. Blood bag temperature was measured using a type-T temperature thermocouple (Physitemp, Clifton, NJ) inserted into the blood bag through a separate port. For each test, a sample of warmed whole blood was reserved for measuring hematocrit, total hemoglobin and baseline plasma free hemoglobin concentrations.</p>
<fig id="fig2-0267659112462733" position="float">
<label>Figure 2.</label>
<caption>
<p>Experimental setup for hemolysis testing. Warm porcine blood is pulled from the blood bag and driven through the CCS by the pump. Blood cools as it travels through the external heat exchanger (EHX) and is delivered through the guide catheter inserted into the mock circulatory in vitro loop. Blood samples are collected from the blood bag and as blood exits the distal tip of the catheter</p>
</caption>
<graphic xlink:href="10.1177_0267659112462733-fig2.tif"/>
</fig>
<p>A mock circulatory in vitro loop was created to mimic human anatomy and physiology.<sup><xref ref-type="bibr" rid="bibr20-0267659112462733">20</xref></sup> The loop continuously circulated blood analog, a 38% glycerol/distilled water mixture by volume, through a glass aortic arch (Vasodyn, Freeville, NY) at a constant physiological aorta flow rate (3500±200mL/min), pressure (100±20mmHg) and temperature (38±0.5°C). Flow is maintained by a peristaltic pump (Ismatec SA, Glattbrugg, Switzerland) (not shown in <xref ref-type="fig" rid="fig2-0267659112462733">Figure 2</xref>). The glass aortic arch includes left and right coronaries, left and right internal carotid arteries and a femoral artery access point for catheter insertion. Aorta flow and pressure were measured using a turbine flowmeter (McMillan, Georgetown, TX) and a high accuracy static pressure transducer calibrated to ±0.3 mmHg (Cole-Parmer, Vernon Hills, IL), respectively. Type-T thermocouples (Physitemp and Blaze Technical Services) were used to measure all blood analog and porcine blood temperatures. All instrument measurement data was collected and recorded using Labview DAQ software (National Instruments, Austin, TX) and post-processed with Matlab (The MathWorks, Natick, MA).</p>
<p>For each test, a commercially available guide catheter was inserted into a femoral access point in the in vitro loop and advanced through the glass arch so that the distal tip exited a carotid branch by 2 cm (<xref ref-type="fig" rid="fig2-0267659112462733">Figure 2</xref>). To investigate several possible clinically relevant applications, the following catheter configurations were used: a 7F guide catheter only, a 7F guide with a 0.038” wire inserted through the center and advanced 2 cm distal to the catheter distal tip, a 6F guide catheter only, and a 6F guide with a 0.014” guidewire similarly inserted through the center (<xref ref-type="table" rid="table1-0267659112462733">Table 1</xref>). Guide catheters and guidewires were manufactured by Cordis Corporation (Bridgewater, NJ) and Boston Scientific (Natick, MA), respectively. The CCS intake or proximal end was connected to the blood bag 12F insertion sheath. The CCS outlet or distal end tubing was connected to the proximal hub of the guide catheter inserted into the in vitro loop. To prepare the EHX, the CCS chiller was set to 0°C and distilled water was circulated through the EHX. Prior to blood circulation, the entire blood loop (traveling through the CCS as well as through the catheter) was flushed with a mixture of saline and ACD.</p>
<table-wrap id="table1-0267659112462733" position="float">
<label>Table 1.</label>
<caption>
<p>Catheter/guidewire test configurations</p>
</caption>
<graphic alternate-form-of="table1-0267659112462733" xlink:href="10.1177_0267659112462733-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Testing Configuration</th>
<th align="left">Catheter Outer Diameter (in)</th>
<th align="left">Catheter Inner Diameter (in)</th>
<th align="left">Insert Outer Diameter (in)</th>
<th align="left">Catheter Length (in)</th>
</tr>
</thead>
<tbody>
<tr>
<td><bold>7F guide catheter only</bold></td>
<td>0.092</td>
<td>0.078</td>
<td>NA</td>
<td>42.13</td>
</tr>
<tr>
<td><bold>7F with 0.038” guidewire</bold></td>
<td>0.092</td>
<td>0.078</td>
<td>0.0345</td>
<td>42.13</td>
</tr>
<tr>
<td><bold>6F guide catheter only</bold></td>
<td>0.079</td>
<td>0.056</td>
<td>NA</td>
<td>40.55</td>
</tr>
<tr>
<td><bold>6F with 0.014” guidewire</bold></td>
<td>0.079</td>
<td>0.056</td>
<td>0.0135</td>
<td>40.55</td>
</tr>
</tbody>
</table></table-wrap>
</sec>
<sec id="section4-0267659112462733">
<title>Testing protocol</title>
<p>For each test configuration, the CCS was operated in a batch mode with blood being drawn from the blood bag, but not recirculated. CCS operating blood delivery flow rate was varied from 50 to 130 mL/min in steps of 20 mL/min. At each flow rate, blood was circulated by the CCS until steady state temperature and flow were achieved. Signals measured and recorded for each test run included: aorta flow rate, temperature and pressure, CCS blood flow rate, driving pressure, blood temperatures for the blood bag - entering the EHX, leaving the EHX, entering the catheter and exiting the distal tip of the catheter. Signal measurements were continuously collected for 30 seconds at a rate of 1 sample/second using Labview DAQ software to provide ample collection time to reduce data variability and minimize blood waste. Two 5-mL samples of blood were collected into plastic 15-mL centrifuge tubes (Fisher Scientific, Pittsburgh, PA) as blood exited the distal tip of the catheter (<xref ref-type="fig" rid="fig2-0267659112462733">Figure 2</xref>). Tests points were repeated 3 times for each operating condition. Each data set was collected from different blood sources (i.e. approximately six different animals with different hematocrits).</p>
</sec>
<sec id="section5-0267659112462733">
<title>Hematocrit and hemoglobin measurements</title>
<p>To measure hematocrit, whole blood was placed inside a 75-µl capillary tube and centrifuged for 15 minutes at 4400 g-force in a microhematocrit centrifuge (LW Scientific, Lawrenceville, GA). For total blood hemoglobin, a 10-μL sample of whole blood was collected on a Hemocue microcuvette and analyzed using the Hemocue Hb 201<sup>+</sup> (Hemocue Inc., Cypress, CA). To measure plasma free hemoglobin, collected blood samples were centrifuged at 1800 g-force for 15 minutes. Pipetted plasma was placed in a cuvette and analyzed using the spectrophotometric method with a SpectroVis Plus spectrophotometer (Vernier Software and Technology, Beaverton, OR). Plasma free hemoglobin absorbance was determined at 540 nm with distilled water as a zero control. This wavelength has been used by other researchers.<sup><xref ref-type="bibr" rid="bibr21-0267659112462733">21</xref>,<xref ref-type="bibr" rid="bibr22-0267659112462733">22</xref></sup></p>
<p>The resulting plasma free hemoglobin concentration was determined using an absorption-to-concentration standard curve created using porcine hemoglobin (Sigma Aldrich, St. Louis, MO). For each test run, blood bag hematocrit, total hemoglobin and plasma free hemoglobin were measured. For each test run, only plasma free hemoglobin was measured at the catheter distal tip, not at individual points along the flow path. The intent of our study was to characterize the overall damage of the CCS.</p>
</sec>
<sec id="section6-0267659112462733">
<title>Hemolysis calculation</title>
<p>To incorporate variation in blood hematocrit and total hemoglobin concentration among blood samples, the degree of hemolysis generation, HG, was calculated using:</p>
<p><disp-formula id="disp-formula3-0267659112462733">
<label>(3)</label>
<mml:math display="block" id="math3-0267659112462733">
<mml:mtable columnalign="left">
<mml:mtr>
<mml:mtd>
<mml:mtext>Degree of hemolysis generation or HG</mml:mtext>
</mml:mtd>
</mml:mtr>
<mml:mtr>
<mml:mtd>
<mml:mo>=</mml:mo><mml:mfrac>
<mml:mrow>
<mml:mi>Δ</mml:mi><mml:mi>p</mml:mi><mml:mi>H</mml:mi><mml:mi>b</mml:mi><mml:mrow><mml:mo>(</mml:mo>
<mml:mrow>
<mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mfrac>
<mml:mrow>
<mml:mi>H</mml:mi><mml:mi>c</mml:mi><mml:mi>t</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>100</mml:mn>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
<mml:mo>)</mml:mo></mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mi>H</mml:mi><mml:mi>b</mml:mi><mml:mo>×</mml:mo><mml:mn>1000</mml:mn><mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mfrac>
<mml:mspace width="0.25em"/><mml:mtext>x</mml:mtext><mml:mn>100</mml:mn><mml:mo>,</mml:mo>
</mml:mtd>
</mml:mtr>
</mml:mtable>
</mml:math>
<graphic alternate-form-of="disp-formula3-0267659112462733" xlink:href="10.1177_0267659112462733-eq3.tif"/>
</disp-formula></p>
<p>with percent free hemoglobin at any location along the CCS flow path calculated with</p>
<p><disp-formula id="disp-formula4-0267659112462733">
<label>(4)</label>
<mml:math display="block" id="math4-0267659112462733">
<mml:mrow>
<mml:mo>%</mml:mo>
<mml:mspace width="0.25em"/>
<mml:mtext>free hemoglobin</mml:mtext>
<mml:mo>=</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mi>p</mml:mi><mml:mi>H</mml:mi><mml:mi>b</mml:mi><mml:mrow><mml:mo>(</mml:mo>
<mml:mrow>
<mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mfrac>
<mml:mrow>
<mml:mi>H</mml:mi><mml:mi>c</mml:mi><mml:mi>t</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>100</mml:mn>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
<mml:mo>)</mml:mo></mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mi>H</mml:mi><mml:mi>b</mml:mi><mml:mo>×</mml:mo><mml:mn>1000</mml:mn><mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mfrac>
<mml:mo>×</mml:mo><mml:mn>100</mml:mn><mml:mo>,</mml:mo>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula4-0267659112462733" xlink:href="10.1177_0267659112462733-eq4.tif"/>
</disp-formula></p>
<p>where Δ<italic>pHb</italic> is the plasma free hemoglobin concentration difference between exit and inlet blood (mg/dL), <italic>Hct</italic> is percentage hematoctrit (%) and <italic>tHb</italic> is total hemoglobin concentration in whole blood (g/dL). Similar formulations are used by other researchers.<sup><xref ref-type="bibr" rid="bibr18-0267659112462733">18</xref>,<xref ref-type="bibr" rid="bibr19-0267659112462733">19</xref>,<xref ref-type="bibr" rid="bibr22-0267659112462733">22</xref>,<xref ref-type="bibr" rid="bibr23-0267659112462733">23</xref></sup> In <xref ref-type="disp-formula" rid="disp-formula3-0267659112462733">Equations (3)</xref> and <xref ref-type="disp-formula" rid="disp-formula4-0267659112462733">(4)</xref>, plasma free hemoglobin is divided by total hemoglobin to normalize the relative amount of hemoglobin not inside red blood cells. Since the volume concentration of red blood cells impacts the amount of mechanical hemolysis, a hematocrit term is used in the numerator of both equations.<sup><xref ref-type="bibr" rid="bibr22-0267659112462733">22</xref></sup></p>
<p>Note that <xref ref-type="disp-formula" rid="disp-formula3-0267659112462733">Equation (3)</xref> does not represent the percentage increase in free hemoglobin: ( pHb<sub>exit</sub> – pHb<sub>inlet</sub>)/pHb<sub>inlet</sub> x 100. Assuming a measurement uncertainty for free hemoglobin, hematocrit and total hemoglobin equal to ±10%, ±0.3%, and ±1.5%, respectively, the combined standard uncertainty for HG and percentage free hemoglobin is less than ±0.02%.</p>
</sec>
<sec id="section7-0267659112462733">
<title>Data analysis and statistics</title>
<p>The independent test parameters were: flow rate, catheter configuration, initial blood makeup, chiller temperature, initial blood temperature and blood analog or “core” temperature. Flow rate and catheter configuration were varied, whereas the other parameters were held constant. Dependent parameters were: system driving pressure, blood temperatures traveling through the system (leaving EHX, and entering and leaving the catheter) and free hemoglobin. Sample means and standard deviations were calculated for each test parameter. The effect of operating flow rates and catheter configurations on the degree of hemolysis generation (HG) were analyzed using an analysis of covariance (ANCOVA) model. The ANCOVA model included fixed effect terms for operating flow rate, catheter configuration, operating flow rate by catheter configuration interaction and degree of hemolysis generation as a covariate. To adjust for multiple comparisons, a Bonferroni adjustment was placed on the significance level. A <italic>p</italic>-value of &lt;0.00125 was considered statistically significant. The <italic>p</italic>-value was determined by taking the original <italic>p</italic>-value at 0.05 and dividing by the total number of possible comparisons: 40. This value (40) is based upon four test configurations that can be compared and 10 different possible flow rates that can be compared (50 mL/min vs. 70 mL/min, 50 mL/min vs. 90 mL/min, etc.). All statistical modeling and hypothesis testing were conducted using SAS Version 9.2 (SAS Institute Inc., Cary, NC).</p>
</sec>
<sec id="section8-0267659112462733">
<title>Results</title>
<sec id="section9-0267659112462733">
<title>Hemolysis</title>
<p>The highest degree of hemolysis generation, HG (<xref ref-type="disp-formula" rid="disp-formula3-0267659112462733">Equation 3</xref>) was 0.11 ±0.04%, based on the average behavior with the 6F catheter with 0.014” wire configuration at a blood flow rate of approximately 130 mL/min (<xref ref-type="fig" rid="fig3-0267659112462733">Figure 3</xref>). With this configuration and flow rate, the percentage of free hemoglobin in the porcine blood exiting the distal tip was 0.17±0.03%, with an inlet or baseline value of 0.06±0.01%. This percentage free hemoglobin is well below the 1% value threshold recommended by the FDA for blood storage and delivery.<sup><xref ref-type="bibr" rid="bibr18-0267659112462733">18</xref></sup></p>
<fig id="fig3-0267659112462733" position="float">
<label>Figure 3.</label>
<caption>
<p>Degree of hemolysis generation (HG) as a function of porcine blood flow rate for four different typical catheter/guidewire configurations. (Refer to <xref ref-type="table" rid="table1-0267659112462733">Table 1</xref> for configuration details.)</p>
</caption>
<graphic xlink:href="10.1177_0267659112462733-fig3.tif"/>
</fig>
<p>Most test configurations for flows ranging from 50-130 mL/min had a degree of hemolysis generation below 0.05% (<xref ref-type="table" rid="table2-0267659112462733">Table 2</xref>). CCS blood exposure times for all configurations at flows ranging from 50 mL/min to 130 mL/min in increments of 20 mL/min were similar: 24.9±0.8, 17.8±0.6, 13.8±0.4, 11.3±04 and 9.6±0.3 seconds, respectively. Based on our experimental uncertainty analysis, any HG values at or below 0.02% were considered negligible, since these values were below the resolution of our measurement technique.</p>
<table-wrap id="table2-0267659112462733" position="float">
<label>Table 2.</label>
<caption>
<p>6F Catheter hemolysis test data<sup><xref ref-type="table-fn" rid="table-fn1-0267659112462733">*</xref></sup></p>
</caption>
<graphic alternate-form-of="table2-0267659112462733" xlink:href="10.1177_0267659112462733-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Flow rate (mL/min)</th>
<th align="left" colspan="5">6F Catheter alone<hr/></th>
<th align="left" colspan="5">6F Catheter with 0.014” wire<hr/></th>
</tr>
<tr>
<th/>
<th align="left">tHb g/dL</th>
<th align="left">Hct %</th>
<th align="left">pHb<sub>bb</sub> mg/dL</th>
<th align="left">pHb<sub>cath</sub> mg/dL</th>
<th align="left">HG %</th>
<th align="left">tHb g/dL</th>
<th align="left">Hct %</th>
<th align="left">pHb<sub>bb</sub> mg/dL</th>
<th align="left">pHb<sub>cath</sub> mg/dL</th>
<th align="left">HG %</th>
</tr>
</thead>
<tbody>
<tr>
<td><bold>50</bold></td>
<td>13.2±1.2</td>
<td>43.4±2.8</td>
<td>13.4±2.9</td>
<td>16.3±2.9</td>
<td>0.0123±0.0012</td>
<td>13.5±1.3</td>
<td>44.1±3.0</td>
<td>14.3±0.5</td>
<td>17.8±1.9</td>
<td>0.0150±0.0084</td>
</tr>
<tr>
<td><bold>70</bold></td>
<td>13.2±1.2</td>
<td>43.4±2.8</td>
<td>13.4±2.9</td>
<td>15.8±3.2</td>
<td>0.0102±0.0022</td>
<td>13.5±1.3</td>
<td>44.1±3.0</td>
<td>14.3±0.5</td>
<td>17.1±1.3</td>
<td>0.0120±0.0055</td>
</tr>
<tr>
<td><bold>90</bold></td>
<td>13.2±1.2</td>
<td>43.4±2.8</td>
<td>13.4±2.9</td>
<td>16.9±3.2</td>
<td>0.0150±0.0021</td>
<td>13.5±1.3</td>
<td>44.1±3.0</td>
<td>14.3±0.5</td>
<td>22.1±6.8</td>
<td>0.0351±0.0326</td>
</tr>
<tr>
<td><bold>110</bold></td>
<td>13.2±1.2</td>
<td>43.4±2.8</td>
<td>13.4±2.9</td>
<td>18.5±2.9</td>
<td>0.0219±0.0018</td>
<td>13.5±1.3</td>
<td>44.1±3.0</td>
<td>14.3±0.5</td>
<td>27.5±3.5</td>
<td>0.0545±0.0123</td>
</tr>
<tr>
<td><bold>130</bold></td>
<td>13.0±1.3</td>
<td>42.4±3.1</td>
<td>12.8±3.9</td>
<td>25.6±3.7</td>
<td>0.0562±0.0205</td>
<td>12.9±0.9</td>
<td>43.3±2.4</td>
<td>13.1±2.2</td>
<td>38.6±11.6</td>
<td>0.1088±0.0396</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0267659112462733">
<label>*</label>
<p>Note: pHbbb and pHbcath are the plasma free hemoglobin for the blood bag and exiting the catheter, respectively. HG, degree of hemolysis generation is defined in <xref ref-type="disp-formula" rid="disp-formula3-0267659112462733">Equation (3)</xref>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="table3-0267659112462733" position="float">
<label>Table 3.</label>
<caption>
<p>7F Catheter hemolysis test data<sup><xref ref-type="table-fn" rid="table-fn2-0267659112462733">*</xref></sup></p>
</caption>
<graphic alternate-form-of="table3-0267659112462733" xlink:href="10.1177_0267659112462733-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Flow rate (mL/min)</th>
<th align="left" colspan="5">7F Catheter alone<hr/></th>
<th align="left" colspan="5">7F Catheter with 0.038” wire<hr/></th>
</tr>
<tr>
<th/>
<th align="left">tHb g/dL</th>
<th align="left">Hct %</th>
<th align="left">pHb<sub>bb</sub> mg/dL</th>
<th align="left">pHb<sub>cath</sub> mg/dL</th>
<th align="left">HG %</th>
<th align="left">tHb g/dL</th>
<th align="left">Hct %</th>
<th align="left">pHb<sub>bb</sub> mg/dL</th>
<th align="left">pHb<sub>cath</sub> mg/dL</th>
<th align="left">HG %</th>
</tr>
</thead>
<tbody>
<tr>
<td><bold>50</bold></td>
<td>13.0±0.9</td>
<td>42.9±2.9</td>
<td>12.0±1.4</td>
<td>14.6±1.6</td>
<td>0.0118±0.0036</td>
<td>13.0±0.8</td>
<td>43.4±2.9</td>
<td>12.0±1.1</td>
<td>14.3±1.6</td>
<td>0.0099±0.0055</td>
</tr>
<tr>
<td><bold>70</bold></td>
<td>13.0±0.9</td>
<td>42.9±2.9</td>
<td>12.0±1.4</td>
<td>14.3±1.3</td>
<td>0.0103±0.0011</td>
<td>13.0±0.8</td>
<td>43.4±2.9</td>
<td>12.0±1.1</td>
<td>12.9±2.1</td>
<td>0.0038±0.0073</td>
</tr>
<tr>
<td><bold>90</bold></td>
<td>13.0±0.9</td>
<td>42.9±2.9</td>
<td>12.0±1.4</td>
<td>13.6±1.6</td>
<td>0.0072±0.0020</td>
<td>13.0±0.8</td>
<td>43.4±2.9</td>
<td>12.0±1.1</td>
<td>16.7±6.5</td>
<td>0.0223±0.0354</td>
</tr>
<tr>
<td><bold>110</bold></td>
<td>13.0±0.9</td>
<td>42.9±2.9</td>
<td>12.0±1.4</td>
<td>13.1±1.2</td>
<td>0.0047±0.0028</td>
<td>13.0±0.8</td>
<td>43.4±2.9</td>
<td>12.0±1.1</td>
<td>13.8±1.7</td>
<td>0.0078±0.0028</td>
</tr>
<tr>
<td><bold>130</bold></td>
<td>13.0±0.9</td>
<td>42.9±2.9</td>
<td>12.0±1.4</td>
<td>13.2±1.8</td>
<td>0.0050±0.0037</td>
<td>12.0±0.8</td>
<td>43.4±2.9</td>
<td>12.0±1.1</td>
<td>19.6±6.7</td>
<td>0.0321±0.0272</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-0267659112462733">
<label>*</label>
<p>Note: pHbbb and pHbcath are the plasma free hemoglobin for the blood bag and exiting the catheter, respectively. HG, degree of hemolysis generation is defined in <xref ref-type="disp-formula" rid="disp-formula3-0267659112462733">Equation (3)</xref>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Results of the two-way ANCOVA yielded a statistically significant interaction between flow rate and catheter configuration. Therefore, main effects comparisons were not conducted. Instead, we chose to examine flow rate comparisons, holding catheter configuration fixed, to determine the effect of flow rate on hemolysis within each individual configuration. This choice was selected since, in the clinical setting, flow rate is more easily altered relative to catheter configuration.</p>
<p>With the Bonferroni adjustment for multiple comparisons, the effect of flow was chosen to be significant if p&lt;0.00125. Only the 6F catheter with the 0.014” wire showed a statistical difference between hemolysis at 130 mL/min compared with that at 50, 70, 90, and 110 mL/min flow rates (<xref ref-type="fig" rid="fig4-0267659112462733">Figure 4</xref>). For all other configurations, hemolysis was not significantly different among flow rates tested.</p>
<fig id="fig4-0267659112462733" position="float">
<label>Figure 4.</label>
<caption>
<p>Degree of hemolysis generation at different blood flow rates for the 6F catheter with 0.014” wire configuration. Error bars show the upper and lower 95% confidence intervals about least square means</p>
</caption>
<graphic xlink:href="10.1177_0267659112462733-fig4.tif"/></fig>
<p>Small variations in baseline blood properties were observed. The average hematocrit and total hemoglobin concentration for all blood tested was 43.4±2.9% and 13.1±1.0 g/dL, respectively. Baseline plasma free hemoglobin concentration was 12.8±1.6 mg/dL, which is approximately 0.06% free hemoglobin when compared to the total hemoglobin (<xref ref-type="disp-formula" rid="disp-formula4-0267659112462733">Equation 4</xref>).</p>
</sec>
<sec id="section10-0267659112462733">
<title>Blood pressure and temperature</title>
<p><xref ref-type="fig" rid="fig5-0267659112462733">Figure 5</xref> shows the system driving pressure used to pump porcine blood through the CCS. The driving pressure represents the pressure required to push the blood through the entire system: the tubing, the EHX and the catheter. Each configuration exhibited laminar flow behavior, with driving pressure increasing linearly with flow rate. At 130 mL/min, the driving pressure of the 6F with 0.014” guidewire configuration is nearly three times the driving pressure of the 7F with no guidewire configuration. This results directly from both a smaller blood pathway and the Poiseuille’s flow equation where pressure drop is proportional to diameter to the fourth power.</p>
<fig id="fig5-0267659112462733" position="float">
<label>Figure 5.</label>
<caption>
<p>Catheter delivery pressure as a function of blood flow rate for four different typical catheter/guidewire configurations. (Refer to <xref ref-type="table" rid="table1-0267659112462733">Table 1</xref> for configuration details.)</p>
</caption>
<graphic xlink:href="10.1177_0267659112462733-fig5.tif"/>
</fig>
<p><xref ref-type="fig" rid="fig6-0267659112462733">Figure 6</xref> shows a typical temperature profile of blood traveling through the CCS. There are four separate blood heat transfer processes: 1) cooling as it exits the blood bag and transfers heat to the ambient environment, 2) cooling as it travels through the external heat exchanger (EHX), 3) rewarming from the ambient environment, and 4) rewarming from the warm blood analog inside the mock circulatory loop.</p>
<fig id="fig6-0267659112462733" position="float">
<label>Figure 6.</label>
<caption>
<p>Average blood temperature along the blood pathway for the 6F with 0.014” guidewire configuration. (Refer to <xref ref-type="fig" rid="fig2-0267659112462733">Figure 2</xref> for blood pathway details.) Other catheter configurations had similar temperature profiles. All measured temperatures had standard deviations of less than 0.7°C</p>
</caption>
<graphic xlink:href="10.1177_0267659112462733-fig6.tif"/>
</fig>
<p>The coolest blood temperatures occur directly after the EHX when blood flow rates are at 50 mL/min. At this flow rate, the blood takes approximately 14 seconds to transit the EHX. At 130 mL/min, this transit time is significantly less: approximately five seconds. The coolest temperature achieved for all configurations and flows was approximately 8°C, occurring at 50 mL/min with a 7F catheter and no guidewire. At this temperature, blood viscosity is approximately two times greater than blood viscosity at 37°C.<sup><xref ref-type="bibr" rid="bibr24-0267659112462733">24</xref></sup></p>
</sec></sec>
</sec>
<sec id="section11-0267659112462733" sec-type="discussion">
<title>Discussion</title>
<p>Our study showed that the CoolGuide Cooling System (CCS) does not generate a clinically significant degree of hemolysis using 6F and 7F catheters over flow ranges from 50 to 130 mL/min. The 6F catheter with a 0.014” wire configuration at 130 mL/min, however, yielded HG that was significantly different to those experienced at lower flow rates (0.11 ±0.04%). This configuration had the smallest internal flow path radius and, as <xref ref-type="disp-formula" rid="disp-formula2-0267659112462733">Equation (2)</xref> shows, shear stress is inversely proportional to the radius cubed. In addition, the behavior of this catheter configuration as flow rates increase was consistent with previous work investigating how mechanically induced hemolysis increases with increasing flow rate.<sup><xref ref-type="bibr" rid="bibr16-0267659112462733">16</xref></sup> For all four configurations tested, we showed that the percentage of free hemoglobin exiting the CCS tissue cooling system does not exceed the 0.8% and 1.0% allowable blood storage guidelines for transfusion established by the Council of Europe and the FDA.<sup><xref ref-type="bibr" rid="bibr18-0267659112462733">18</xref>,<xref ref-type="bibr" rid="bibr25-0267659112462733">25</xref></sup></p>
<p>Nevertheless, a primary limitation for this study is that hemolysis thresholds are not well established for our specific application: rapid localized infusion of cooled blood to an ischemic organ. In fact, the FDA has no specific FDA guidance document recommending a “safe hemolysis threshold”. This is due to the variability in blood-circulating device designs, intended uses, test methodologies and expected patient populations.<sup><xref ref-type="bibr" rid="bibr26-0267659112462733">26</xref></sup> Despite this fact, examining similar or related systems is worthwhile.</p>
<p>Rapid infusion systems like the Level 1 System 1000 (Level 1 Technologies Inc., Rockland MA) have similar configurations compared to the CCS. Kim et al. performed a hemolysis study of the Level 1 system in a trauma setting where more than 10 units of human blood are needed.<sup><xref ref-type="bibr" rid="bibr23-0267659112462733">23</xref></sup> Using a total of 33 units of packed red blood cells, a 16 gauge angiocatheter, a 170 µm filter and intravenous tubing, they showed that the degree of hemolysis generation (HG) was below 0.05% for all units of human blood. While the study reports that flow rates up to 950 mL/min at body temperature are possible, based on the Barcelona et al. work<sup><xref ref-type="bibr" rid="bibr27-0267659112462733">27</xref></sup> and assuming that the viscosity ratio of blood to lactated Ringer’s solution is about three to one, the approximate blood flow rate for the Kim et al. study can be estimated to be about 120 mL/min. Overall, it appears that HG values for the Level 1 rapid infusion system and the CCS are similar, 0.05% vs. 0.11%, respectively.</p>
<p>Other researchers studied hemolysis from the perspective of needle size and blood salvage systems. Sharp et al., in 1998, measured hemolysis using different needles with human blood. The most damaging configuration, a 22 gauge polyurethane cannula, yielded over 1,000 mg/dL in plasma free hemoglobin.<sup><xref ref-type="bibr" rid="bibr13-0267659112462733">13</xref></sup> A typical 2-day-old unit of unfiltered packed red blood cells has a plasma free concentration of about 17 mg/dL.<sup><xref ref-type="bibr" rid="bibr18-0267659112462733">18</xref></sup> Waters et al. studied hemolysis for human blood suctioned from flat surfaces for use in blood retrieval salvage, showing that the maximum plasma free hemoglobin was around 304 mg/dL.<sup><xref ref-type="bibr" rid="bibr22-0267659112462733">22</xref></sup> Ahn et al. also studied human autologous cell salvage. Using two different suction pressures, three different suction tip geometries and two air contact configurations, the maximum plasma free hemoglobin was 71.6±37.4 mg/dL.<sup><xref ref-type="bibr" rid="bibr28-0267659112462733">28</xref></sup> In comparison, our study showed a maximum concentration of 38.6 ±11.6 mg/dL.</p>
<p>We acknowledge that the safe threshold for hemolysis generation for our application is unknown because the impact of delivering slightly higher than baseline free hemoglobin in cooled blood directly to an ischemic organ is unknown. Since this was not a powered study, the relationships between flow rates and hemolysis should be studied with a larger number of replicates. Future work will investigate these thresholds, taking into account parameters that can reduce hemolysis generation: flow rate, geometry, material properties and duration of use. To achieve regulatory approval, this work will also extend into other blood trauma categories, including complement activation, platelet activation and thrombus formation. This study, however, represents important first evidence demonstrating that hemolysis generation arising from our localized organ cooling system (CCS) is likely to be clinically insignificant.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>Our work was supported by NIH’s National Institute for Neurological Disorders and Stroke (NINDS), Grant Number: 1R43NS073291. The content is solely the responsibility of the authors and does not necessarily represent the official view of NINDS or NIH.</p>
</fn>
<fn fn-type="conflict">
<label>Conflict of interest statement</label>
<p>Authors T. L. Merrill, D. R. Merrill, and J. E. Akers all work for and have ownership in FocalCool, LLC, the company conducting this research. FocalCool, LLC is a medical device research and development startup company. FocalCool, LLC is developing an organ-specific cooling system to reduce tissue damage from ischemia and reperfusion injury.</p>
<p>Authors J. Botbyl and Todd Mingin have no conflicts of interest.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0267659112462733">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gotberg</surname><given-names>M</given-names></name>
<name><surname>Olivecrona</surname><given-names>GK</given-names></name>
<name><surname>Engblom</surname><given-names>H</given-names></name>
<etal/></person-group>. <article-title>Rapid short-duration hypothermia with cold saline and endovascular cooling before reperfusion reduces microvascular obstruction and myocardial infarct size</article-title>. <source>BMC Cardiovasc Disord</source> <year>2008</year>; <volume>8</volume>: <fpage>7</fpage>.</citation>
</ref>
<ref id="bibr2-0267659112462733">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>van der Worp</surname><given-names>HB</given-names></name>
<name><surname>Sena</surname><given-names>ES</given-names></name>
<name><surname>Donnan</surname><given-names>GA</given-names></name>
<name><surname>Howells</surname><given-names>DW</given-names></name>
<name><surname>Macleod</surname><given-names>M</given-names></name>
</person-group>. <article-title>Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis</article-title>. <source>Brain</source> <year>2007</year>; <volume>130</volume>: <fpage>3063</fpage>–<lpage>3074</lpage>.</citation>
</ref>
<ref id="bibr3-0267659112462733">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Polderman</surname><given-names>KH</given-names></name>
</person-group>. <article-title>Application of therapeutic hypothermia in the ICU: opportunities and pitfalls of a promising treatment modality. Part 1: Indications and evidence</article-title>. <source>Intensive Care Med</source> <year>2004</year>; <volume>30</volume>: <fpage>556</fpage>–<lpage>575</lpage>.</citation>
</ref>
<ref id="bibr4-0267659112462733">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>CY</given-names></name>
<name><surname>Ni</surname><given-names>Y</given-names></name>
<name><surname>Liu</surname><given-names>Y</given-names></name>
<etal/></person-group>. <article-title>Mild hypothermia protects liver against ischemia and reperfusion injury</article-title>. <source>World J Gastroenterol</source> <year>2005</year>; <volume>11</volume>: <fpage>3005</fpage>–<lpage>3007</lpage>.</citation>
</ref>
<ref id="bibr5-0267659112462733">
<label>5.</label>
<citation citation-type="web">
<person-group person-group-type="author">
<name><surname>Grines</surname><given-names>CL</given-names></name>
</person-group>. <article-title>ICE-IT-1: Intravascular cooling adjunctive to percutaneous coronary intervention (part 1)</article-title>, available at <ext-link ext-link-type="uri" xlink:href="http://www.tctmd.com/csportal/appmanager/tctmd/main?_nfpb=true&amp;_pageLabel=TCTMDContent&amp;hdCon=869491,TCTMD.com">www.tctmd.com/csportal/appmanager/tctmd/main?_nfpb=true&amp;_pageLabel=TCTMDContent&amp;hdCon=869491,TCTMD.com</ext-link>, <access-date>Accessed March 1, 2012</access-date>, <year>2004</year>.</citation>
</ref>
<ref id="bibr6-0267659112462733">
<label>6.</label>
<citation citation-type="web">
<person-group person-group-type="author">
<name><surname>O’Neill</surname><given-names>WW</given-names></name>
</person-group>. <article-title>A prospective, randomized trial of mild systemic hypothermia during PCI treatment of ST elevation MI</article-title>, available at: <ext-link ext-link-type="uri" xlink:href="http://www.tctmd.com/csportal/appmanager/tctmd/main?_nfpb=true&amp;_pageLabel=TCTMDContent&amp;hdCon=869491,TCTMD.com">http://www.tctmd.com/csportal/appmanager/tctmd/main?_nfpb=true&amp;_pageLabel=TCTMDContent&amp;hdCon=869491,TCTMD.com</ext-link>. <access-date>Accessed March 1, 2012</access-date>, <year>2003</year>.</citation>
</ref>
<ref id="bibr7-0267659112462733">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kurz</surname><given-names>A</given-names></name>
<name><surname>Sessler</surname><given-names>DI</given-names></name>
<name><surname>Narzt</surname><given-names>E</given-names></name>
<etal/></person-group>. <article-title>Postoperative hemodynamic and thermoregulatory consequences of intraoperative core hypothermia</article-title>. <source>J Clin Anesth</source> <year>1995</year>; <volume>7</volume>: <fpage>359</fpage>–<lpage>366</lpage>.</citation>
</ref>
<ref id="bibr8-0267659112462733">
<label>8.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Akca</surname><given-names>O</given-names></name>
</person-group>. <article-title>Complications of hypothermia</article-title>. In: <person-group person-group-type="editor">
<name><surname>Akca</surname><given-names>O</given-names></name>
</person-group>, ed. <source>Therapeutic hypothermia</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Marceal Dekker</publisher-name>; <year>2005</year>: pp<fpage>189</fpage>.</citation>
</ref>
<ref id="bibr9-0267659112462733">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Akers</surname><given-names>JE</given-names></name>
<name><surname>Merrill</surname><given-names>DR</given-names></name>
<name><surname>Nilsen</surname><given-names>TJ</given-names></name>
<etal/></person-group>. <article-title>Localized cooling device for myocardial tissue salvage</article-title>. <source>ASME 2011 Summer Bioengineering Conference</source> <year>2011</year>; <fpage>SBC2011</fpage>–<lpage>53155</lpage>.</citation>
</ref>
<ref id="bibr10-0267659112462733">
<label>10.</label>
<citation citation-type="book"><article-title>Biological evaluation of medical devices - part 4: Selection of tests for interactions with blood</article-title>. <source>International Standard</source> <year>2002</year>; ISO 10993–4 (<publisher-loc>Geneva Switzerland</publisher-loc>).</citation>
</ref>
<ref id="bibr11-0267659112462733">
<label>11.</label>
<citation citation-type="other"><article-title>ASTM F1841-97: Standard practice for assessment of hemolysis in continuous flow blood pumps</article-title>, <year>2005</year>.</citation>
</ref>
<ref id="bibr12-0267659112462733">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Leverett</surname><given-names>LB</given-names></name>
<name><surname>Hellums</surname><given-names>JD</given-names></name>
<name><surname>Alfrey</surname><given-names>CP</given-names></name>
<name><surname>Lynch</surname><given-names>EC</given-names></name>
</person-group>. <article-title>Red blood cell damage by shear stress</article-title>. <source>Biophys J</source> <year>1972</year>; <volume>12</volume>: <fpage>257</fpage>–<lpage>273</lpage>.</citation>
</ref>
<ref id="bibr13-0267659112462733">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sharp</surname><given-names>MK</given-names></name>
<name><surname>Mohammad</surname><given-names>SF</given-names></name>
</person-group>. <article-title>Scaling of hemolysis in needles and catheters</article-title>. <source>Ann Biomed Eng</source> <year>1998</year>; <volume>26</volume>: <fpage>788</fpage>–<lpage>797</lpage>.</citation>
</ref>
<ref id="bibr14-0267659112462733">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Parfitt</surname><given-names>HS</given-names></name>
<name><surname>Davies</surname><given-names>SV</given-names></name>
<name><surname>Tighe</surname><given-names>P</given-names></name>
<name><surname>Ewings</surname><given-names>P</given-names></name>
</person-group>. <article-title>Red cell damage after pumping by two infusion control devices (arcomed VP 7000 and IVAC 572)</article-title>. <source>Transfus Med</source> <year>2007</year>; <volume>17</volume>: <fpage>290</fpage>–<lpage>295</lpage>.</citation>
</ref>
<ref id="bibr15-0267659112462733">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mulholland</surname><given-names>JW</given-names></name>
<name><surname>Massey</surname><given-names>W</given-names></name>
<name><surname>Shelton</surname><given-names>JC</given-names></name>
</person-group>. <article-title>Investigation and quantification of the blood trauma caused by the combined dynamic forces experienced during cardiopulmonary bypass</article-title>. <source>Perfusion</source> <year>2000</year>; <volume>15</volume>: <fpage>485</fpage>–<lpage>494</lpage>.</citation>
</ref>
<ref id="bibr16-0267659112462733">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kameneva</surname><given-names>MV</given-names></name>
<name><surname>Burgreen</surname><given-names>GW</given-names></name>
<name><surname>Kono</surname><given-names>K</given-names></name>
<name><surname>Repko</surname><given-names>B</given-names></name>
<name><surname>Antaki</surname><given-names>JF</given-names></name>
<name><surname>Umezu</surname><given-names>M</given-names></name>
</person-group>. <article-title>Effects of turbulent stresses upon mechanical hemolysis: experimental and computational analysis</article-title>. <source>ASAIO J</source> <year>2004</year>; <volume>50</volume>: <fpage>418</fpage>–<lpage>423</lpage>.</citation>
</ref>
<ref id="bibr17-0267659112462733">
<label>17.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Fournier</surname><given-names>RL</given-names></name>
</person-group>. <article-title>The physical and flow properties of blood and other fluids</article-title>. In: <source>Basic transport phenomena in biomedical engineering</source>. <edition>3rd ed.</edition> <publisher-loc>New York, NY</publisher-loc>: <publisher-name>CRC Press</publisher-name>; <year>2012</year>: pp<fpage>121</fpage>–<lpage>174</lpage>.</citation>
</ref>
<ref id="bibr18-0267659112462733">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sowemimo-Coker</surname><given-names>SO</given-names></name>
</person-group>. <article-title>Red blood cell hemolysis during processing</article-title>. <source>Transfus Med Rev</source> <year>2002</year>; <volume>16</volume>: <fpage>46</fpage>–<lpage>60</lpage>.</citation>
</ref>
<ref id="bibr19-0267659112462733">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Paul</surname><given-names>R</given-names></name>
<name><surname>Apel</surname><given-names>J</given-names></name>
<name><surname>Klaus</surname><given-names>S</given-names></name>
<name><surname>Schugner</surname><given-names>F</given-names></name>
<name><surname>Schwindke</surname><given-names>P</given-names></name>
<name><surname>Reul</surname><given-names>H</given-names></name>
</person-group>. <article-title>Shear stress related blood damage in laminar couette flow</article-title>. <source>Artif Organs</source> <year>2003</year>; <volume>27</volume>: <fpage>517</fpage>–<lpage>529</lpage>.</citation>
</ref>
<ref id="bibr20-0267659112462733">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Merrill</surname><given-names>TL</given-names></name>
<name><surname>Merrill</surname><given-names>DR</given-names></name>
<name><surname>Nilsen</surname><given-names>TJ</given-names></name>
<name><surname>Akers</surname><given-names>JE</given-names></name>
</person-group>. <article-title>Design of a cooling guide catheter for rapid heart cooling</article-title>. <source>J Medical Devices</source> <year>2010</year>; <volume>4</volume>: doi:<pub-id pub-id-type="doi">10.1115/1.4002063</pub-id>.</citation>
</ref>
<ref id="bibr21-0267659112462733">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lund</surname><given-names>LW</given-names></name>
<name><surname>Hattler</surname><given-names>BG</given-names></name>
<name><surname>Federspiel</surname><given-names>WJ</given-names></name>
</person-group>. <article-title>A comparative in vitro hemolysis study of a pulsating intravenous artificial lung</article-title>. <source>ASAIO J</source> <year>2002</year>; <volume>48</volume>: <fpage>631</fpage>–<lpage>635</lpage>.</citation>
</ref>
<ref id="bibr22-0267659112462733">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Waters</surname><given-names>JH</given-names></name>
<name><surname>Williams</surname><given-names>B</given-names></name>
<name><surname>Yazer</surname><given-names>MH</given-names></name>
<name><surname>Kameneva</surname><given-names>MV</given-names></name>
</person-group>. <article-title>Modification of suction-induced hemolysis during cell salvage</article-title>. <source>Anesth Analg</source> <year>2007</year>; <volume>104</volume>: <fpage>684</fpage>–<lpage>687</lpage>.</citation>
</ref>
<ref id="bibr23-0267659112462733">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>P</given-names></name>
<name><surname>Chin-Yee</surname><given-names>I</given-names></name>
<name><surname>Eckert</surname><given-names>K</given-names></name>
<name><surname>Malthaner</surname><given-names>RA</given-names></name>
<name><surname>Gray</surname><given-names>DK</given-names></name>
</person-group>. <article-title>Hemolysis with rapid transfusion systems in the trauma setting</article-title>. <source>Can J Surg</source> <year>2004</year>; <volume>47</volume>: <fpage>295</fpage>–<lpage>297</lpage>.</citation>
</ref>
<ref id="bibr24-0267659112462733">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Merrill</surname><given-names>EW</given-names></name>
</person-group>. <article-title>Rheology of blood</article-title>. <source>Physiological Reviews</source>. <year>1969</year>; <volume>49</volume>: <fpage>863</fpage>–<lpage>888</lpage>.</citation>
</ref>
<ref id="bibr25-0267659112462733">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bhatia</surname><given-names>A</given-names></name>
<name><surname>Majid</surname><given-names>A</given-names></name>
<name><surname>Rosamma</surname><given-names>N</given-names></name>
<etal/></person-group>., <article-title>Evaluation of the red cell hemolysis in packed red cells during processing and storage</article-title>. <source>Asian J Transfus Sci</source> <year>2011</year>; <volume>5</volume>: <fpage>15</fpage>–<lpage>17</lpage>.</citation>
</ref>
<ref id="bibr26-0267659112462733">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Renaldi</surname><given-names>JE</given-names></name>
<name><surname>Malinauskas</surname><given-names>RA</given-names></name>
</person-group>. <article-title>Private communication: Center for devices and radiological health food and drug administration</article-title>. <month>April</month> <volume>26</volume>, <year>2012</year>.</citation>
</ref>
<ref id="bibr27-0267659112462733">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Barcelona</surname><given-names>SL</given-names></name>
<name><surname>Vilich</surname><given-names>F</given-names></name>
<name><surname>Coté</surname><given-names>CJ</given-names></name>
</person-group>. <article-title>A comparison of flow rates and warming capabilities of the Level 1 and Rapid Infusion System with various-size intravenous catheters</article-title>. <source>Anesth Analg</source> <year>2003</year>; <volume>97</volume>(<issue>2</issue>): <fpage>358</fpage>–<lpage>363</lpage>. doi: <pub-id pub-id-type="doi">10.1213/01.ANE.0000070235.67887.5C</pub-id>.</citation>
</ref>
<ref id="bibr28-0267659112462733">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>An</surname><given-names>S</given-names></name>
<name><surname>Choi</surname><given-names>ES</given-names></name>
<name><surname>Ahn</surname><given-names>W</given-names></name>
</person-group>. <article-title>Suction conditions for minimizing the production of free hemoglobin during blood salvage using an autotransfusion apparatus</article-title>. <source>Korean J Anesthesiol</source> <year>2011</year>; <volume>60</volume>: <fpage>266</fpage>–<lpage>271</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>